Source: International Journal of Infectious Diseases Highlights As of May27, 2020 there are over 1,678,843 confirmed cases of COVID-19 claiming more than 100,000 lives in
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
Hydroxychloroquine use was associated with decreased mortality.
Our data suggest that chronic treatment with HCQ confer protection against SARS-CoV-2 infection.
No life-threatening modifications of the QT interval was observed in non-severe COVID-19 patients treated ambulatory with hydroxychloroquine and azithromycin. Studies are needed in critical-ill and older patients.
The clinical trials on this list are studying Hydroxychloroquine. All trials on the list are supported by NCI.
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to 2020 and may challenge global health in the future. There
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
Alex Azar explains that the HCQ EUA revoke, means it is available to anyone with a script Source: FDA letter revolking EUA status On the
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
Preface: On May 22, The Lancet published a study of 96,000 COVID-19 patients stating Hydroxychloroquine had no value in treating COVID-19 and even suggested increased
On the 25th of May 2020, the World Health Organisation halted hyrdoxychloroquine trials globally within 72 hours of sighting a publication in the Lancet. They
Source: The Lancet Expression of concern: Hydroxychloroquine or chloroquinewith or without a macrolide for treatment of COVID-19:a multinational registry analysis. Important scientific questions have been
Source: AAPS Today, June 2, 2020, the Association of American Physicians & Surgeons (AAPS) filed a lawsuit, AAPS v. FDA, against the Food and Drug Administration
Source: Brazil Ministry of Foreign Relations The Brazilian people and the North American people show solidarity in the fight against the coronavirus. Today, as a demonstration
Source: The White House The American and Brazilian people stand in solidarity in the fight against the coronavirus. Today, as a demonstration of that solidarity,
Source: Medrxiv View ORCID Profile Amanda Chamieh, Claude Afif, View ORCID Profile Gerard El-Hajj, View ORCID Profile Omar Zmerli, Isabelle Djaffar-Jureidini,View ORCID Profile Roy A. Raad, Raja Ashou, George Juvelekian,View ORCID Profile Jean-Marc Rolain,View ORCID Profile Eid Azar doi: https://doi.org/10.1101/2020.05.28.20114835 This article
Source: Mediterranee Infection COVID-IHU #15 Version 1 du 27 Mai 2020Early diagnosis and management of COVID-19 patients: a real-life cohort study of 3,737 patients, Marseille, France Abstract Background:In our institute in Marseille, France, we
Source: Zendo In an open letter to MR Mehra, SS Desai, F Ruschitzka, and AN Patel, authors of “Hydroxychloroquine or chloroquine with or without a
Source: Oxford Academic – American Journal of Endimology Original unedited manuscript as PDF Abstract More than 1.6 million Americans have been infected with SARS-CoV-2 and
Source: armenpress YEREVAN, MAY 27, ARMENPRESS. The Armenian Healthcare Ministry says the efficiency of the use of hydroxychloroquine for treating COVID-19 patients aren’t yet fully summed
Source: Mediterranee Infection Why this discrepancy between the preprint version and the version published in the BMJ? Tang et al. – Data (text and figures) evidencing
Source: Recovery Trial Professor Peter Horby, Professor Martin LandrayRECOVERY trial Co-chairsNuffield Department of Public HealthOxford24th May 2020 Dear Peter and Martin RECOVERY trial DMC Chairman’s
Source: Indian Council of Medical Research 1. Background The Joint Monitoring Group under the Chairmanship of DGHS and including representatives from AIIMS, ICMR, NCDC, NDMA,
Source: SagePub.com Convalescent blood products are promising potential therapies for COVID-19. Other antivirals such as chloroquine or HCQ, remdesivir, and immune modulators such as tocilizumab
Source: Real Clear Politics VA Secretary Robert Wilkie fact-checked a common misconception about the common anti-malarial drug Hydroxychloroquine after the president was asked about it
How can one person brag about blocking physicians’ attempt to reduce hospitalization and deaths during a national emergency?
SOURCE: CNBC News President Donald Trump said Monday that he has been taking anti-malaria drug hydroxychloroquine for a couple of weeks to prevent coronavirus infection even though the media
SOURCE: Covexit.com The esteemed professor Paolo Zanotto, from the University of Sao Paulo, has released a list of 50 scientific references supporting the use of
Source: The White House His ExcellencyTHE WHITE HOUSEWASHINGTONMay 18, 2020 Dr. Tedros Adhanom GhebreyesusDirector-General of the World Health OrganizationGeneva, Switzerland Dear Dr. Tedros: On April
Source: Springer Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high fatality. The most urgent need is to find effective treatments.
Source: MedRxiv Repurposed drugs that are immediately available and have a good safety profile constitute a first line of defence against new viral infections. Despite
Source: Preprints Although no specific treatment for COVID 19 has been proven effective yet, some drugs with in vitro potential against SARS-CoV-2 virus have been
Source: MedRxiv Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis
Source: Science Direct Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is used in the treatment of COVID-19. Methods We retrospectively report
Source: MedRxiv Background Effective therapies are urgently needed for the SARS-CoV-2 pandemic. Chloroquine has been proved to have antiviral effect against coronavirus in vitro. In
